Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Adherence to American Thoracic Society (ATS) diagnostic criteria when treating non-tuberculous mycobacterial species over 7 years at Queen Alexandra Hospital (QAH), Portsmouth, England

Hannah Schiff, Sophie Philpot, Andrew Achaiah, Georgina Boyes, Adriana Pereira, Ben Green
European Respiratory Journal 2016 48: PA2569; DOI: 10.1183/13993003.congress-2016.PA2569
Hannah Schiff
1Respiratory Medicine, Portsmouth Hospitals NHS Trust, Portsmouth, HampshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Philpot
1Respiratory Medicine, Portsmouth Hospitals NHS Trust, Portsmouth, HampshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Achaiah
1Respiratory Medicine, Portsmouth Hospitals NHS Trust, Portsmouth, HampshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgina Boyes
1Respiratory Medicine, Portsmouth Hospitals NHS Trust, Portsmouth, HampshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriana Pereira
1Respiratory Medicine, Portsmouth Hospitals NHS Trust, Portsmouth, HampshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Green
1Respiratory Medicine, Portsmouth Hospitals NHS Trust, Portsmouth, HampshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Background: The frequency of clinical isolation of NTM in the UK is increasing. ATS diagnostic criteria aid the identification of clinically relevant isolates causing lung disease.

Objective: To audit the diagnostic criteria used when treating NTM at QAH.

Methods: Records of all patients from whom NTM were isolated from respiratory samples between 2007 and 2014 were reviewed. Microbiological results, radiological findings and symptoms were reviewed to assess adherence to ATS diagnostic criteria.

Results: NTM were isolated from the respiratory tract in 514 patients. 91 patients were treated for NTM disease. 4 patients did not meet ATS diagnostic criteria. Of these, two patients with M. avium were treated following multiple isolates with symptoms on a background of bronchiectasis without nodular or cavitatory change. One patient with M. intracellulare was treated following a single sputum isolate and a second patient did not meet the radiological criteria for ATS definition. Results for a selection of species are presented below.

SpeciesNo. of patients with at least one positive isolateNo. of patients treated% of patients treated% of treated patients meeting ATS criteriaNo. of AFB smear positive samples
Intracellulare12937299525/270
Avium7716218812/187
Abscessus16106310028/81
Xenopi468171006/77
Malmoense187391005/40
Kansasii96671001/16
Gordonae1150001/123

Selected results

Conclusion: 18% of all patients with pulmonary NTM isolates were treated for NTM infection. 96% of treated cases met the ATS diagnostic criteria suggesting good adherence to guidance.

  • Bacteria
  • Infections
  • Bronchiectasis
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adherence to American Thoracic Society (ATS) diagnostic criteria when treating non-tuberculous mycobacterial species over 7 years at Queen Alexandra Hospital (QAH), Portsmouth, England
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Adherence to American Thoracic Society (ATS) diagnostic criteria when treating non-tuberculous mycobacterial species over 7 years at Queen Alexandra Hospital (QAH), Portsmouth, England
Hannah Schiff, Sophie Philpot, Andrew Achaiah, Georgina Boyes, Adriana Pereira, Ben Green
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2569; DOI: 10.1183/13993003.congress-2016.PA2569

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Adherence to American Thoracic Society (ATS) diagnostic criteria when treating non-tuberculous mycobacterial species over 7 years at Queen Alexandra Hospital (QAH), Portsmouth, England
Hannah Schiff, Sophie Philpot, Andrew Achaiah, Georgina Boyes, Adriana Pereira, Ben Green
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2569; DOI: 10.1183/13993003.congress-2016.PA2569
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Genetic homology between bacteria in pus from the pyothorax and bacteria in the oral cavity in patients with pyothorax
  • In vitro evaluation of the Twincer colistin dry powder inhaler as a non-cough-inducing alternative to Colobreathe
  • Clinical and radiological features of pneumocystis pneumonia in immunocompromised non-HIV patients
Show more 10.1 Respiratory Infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society